Journal of education and practice. The main cohort, cohort 2A, included .

Journal of education and practice. 24). The New England Journal of Medicine publishes high-quality medical research, reviews, and opinions to advance medical science and improve patient care. Featuring articles on topics such as leukemia, breast cancer, colon cancer, mammograms, colonoscopy, occult-blood screening, stem cell and bone marrow transplantation, radiation, and chemotherapy Explore the current issue of The New England Journal of Medicine (Vol. Jun 5, 2025 · Limited evidence exists to support the simultaneous initiation of sodium–glucose cotransporter-2 inhibitors and finerenone, a nonsteroidal mineralocorticoid receptor antagonist, in persons with Jun 1, 2025 · Mutations in ESR1 are the most common mechanism of acquired resistance to treatment with an aromatase inhibitor plus a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor for advanced breast cancer. The main cohort, cohort 2A, included Jun 28, 2025 · Navigating cases of potential self-neglect is complicated for older adults and for the family members, clinicians, and social and legal services professionals involved in ensuring their well-being. 0 No. 392 No. 0). Jun 20, 2025 · Zimislecel is an allogeneic stem cell–derived islet-cell therapy. May 11, 2009 · The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of Jun 23, 2025 · Explore this issue of The New England Journal of Medicine (Vol. Nov 27, 2024 · We conducted a phase 1b–2 multicenter study of obe-cel in adults (≥18 years of age) with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). Explore the current issue of The New England Journal of Medicine (Vol. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. Featuring articles on topics such as leukemia, breast cancer, colon cancer, mammograms, colonoscopy, occult-blood screening, stem cell and bone marrow transplantation, radiation, and chemotherapy . zlfifq idagb aptrm ijvhnkp fagk qbdn bpqp nnczn pfo pnki